The immunosuppressant FK-506 prevents progression of diabetes in nonobese diabetic mice
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 57 (2) , 274-279
- https://doi.org/10.1016/0090-1229(90)90041-n
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- Immunosuppressive effect of FK506 on collagen-induced arthritis in ratsClinical Immunology and Immunopathology, 1988
- STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATSTransplantation, 1987
- STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOGTransplantation, 1987
- Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD miceDiabetes, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987
- Preventive effects of Cyclosporin on diabetes in NOD miceDiabetologia, 1986
- Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamideDiabetologia, 1984
- Breeding of a Non-Obese, Diabetic Strain of MiceExperimental Animals, 1980